These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30859903)

  • 21. Family-Joining: A Fast Distance-Based Method for Constructing Generally Labeled Trees.
    Kalaghatgi P; Pfeifer N; Lengauer T
    Mol Biol Evol; 2016 Oct; 33(10):2720-34. PubMed ID: 27436007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subgroup identification for treatment selection in biomarker adaptive design.
    Lu TP; Chen JJ
    BMC Med Res Methodol; 2015 Dec; 15():105. PubMed ID: 26646831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A general statistical framework for subgroup identification and comparative treatment scoring.
    Chen S; Tian L; Cai T; Yu M
    Biometrics; 2017 Dec; 73(4):1199-1209. PubMed ID: 28211943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tree-space statistics and approximations for large-scale analysis of anatomical trees.
    Feragen A; Owen M; Petersen J; Wille MM; Thomsen LH; Dirksen A; de Bruijne M
    Inf Process Med Imaging; 2013; 23():74-85. PubMed ID: 24683959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of the interim analysis in adaptive enrichment designs.
    Benner L; Kieser M
    J Biopharm Stat; 2018; 28(4):622-632. PubMed ID: 29064745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.
    Coull BA; Bobb JF; Wellenius GA; Kioumourtzoglou MA; Mittleman MA; Koutrakis P; Godleski JJ
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):5-50. PubMed ID: 26333238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Work efficiency: a new criterion for comprehensive comparison and evaluation of statistical methods in large-scale identification of differentially expressed genes.
    Tan YD
    Genomics; 2011 Nov; 98(5):390-9. PubMed ID: 21741470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying predictive markers for personalized treatment selection.
    Shen Y; Cai T
    Biometrics; 2016 Dec; 72(4):1017-1025. PubMed ID: 26999054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subgroup analysis with semiparametric models toward precision medicine.
    Yuan A; Chen X; Zhou Y; Tan MT
    Stat Med; 2018 May; 37(11):1830-1845. PubMed ID: 29575056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cross-validated AUC for MCP-logistic regression with high-dimensional data.
    Jiang D; Huang J; Zhang Y
    Stat Methods Med Res; 2013 Oct; 22(5):505-18. PubMed ID: 22127580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modified classification tree method for personalized medicine decisions.
    Tsai WM; Zhang H; Buta E; O'Malley S; Gueorguieva R
    Stat Interface; 2016; 9(2):239-253. PubMed ID: 26770292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian additive decision trees of biomarker by treatment interactions for predictive biomarker detection and subgroup identification.
    Zhao Y; Zheng W; Zhuo DY; Lu Y; Ma X; Liu H; Zeng Z; Laird G
    J Biopharm Stat; 2018; 28(3):534-549. PubMed ID: 29020511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validating effectiveness of subgroup identification for longitudinal data.
    Andrews N; Cho H
    Stat Med; 2018 Jan; 37(1):98-106. PubMed ID: 28948635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quint: An R package for the identification of subgroups of clients who differ in which treatment alternative is best for them.
    Dusseldorp E; Doove L; Mechelen Iv
    Behav Res Methods; 2016 Jun; 48(2):650-63. PubMed ID: 26092391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian credible subgroup identification for treatment effectiveness in time-to-event data.
    Ngo D; Baumgartner R; Mt-Isa S; Feng D; Chen J; Schnell P
    PLoS One; 2020; 15(2):e0229336. PubMed ID: 32101562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploratory factor analysis for small samples.
    Jung S; Lee S
    Behav Res Methods; 2011 Sep; 43(3):701-9. PubMed ID: 21431996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree.
    Shen C; Hu Y; Li X; Wang Y; Chen PS; Buxton AE
    Biom J; 2016 Nov; 58(6):1357-1375. PubMed ID: 27356196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model selection for mixtures of mutagenetic trees.
    Yin J; Beerenwinkel N; Rahnenführer J; Lengauer T
    Stat Appl Genet Mol Biol; 2006; 5():Article17. PubMed ID: 17049028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Random forests of interaction trees for estimating individualized treatment effects in randomized trials.
    Su X; Peña AT; Liu L; Levine RA
    Stat Med; 2018 Jul; 37(17):2547-2560. PubMed ID: 29707855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.